The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 21, 2023

Filed:

Sep. 21, 2020
Applicant:

Hadasit Medical Research Services and Development Ltd., Jerusalem, IL;

Inventor:

Dana Wolf, Mevaseret Zion, IL;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/541 (2006.01); A61P 31/12 (2006.01); A61K 31/517 (2006.01); A61K 31/522 (2006.01); A61K 31/675 (2006.01); A61K 31/7056 (2006.01);
U.S. Cl.
CPC ...
A61K 31/541 (2013.01); A61K 31/517 (2013.01); A61K 31/522 (2013.01); A61K 31/675 (2013.01); A61K 31/7056 (2013.01); A61P 31/12 (2018.01);
Abstract

The present invention provides compositions and methods for treating, preventing, and inhibiting viral replication, viral infections and viral diseases and disorders, comprising use of artemisone in combination with at least one antiviral compound selected from maribavir, cidofovir, brincidofovir, valganciclovir, and letermovir, and the combination provides a synergistic anti-viral effect. The invention also provides compositions and methods for treating, preventing, and inhibiting viral replication, viral infections and viral diseases and disorders, comprising the use of artemisone in combination with ganciclovir, wherein the molar ratio between artemisone and ganciclovir is about 1:100 to 100:1, and the combination provides a synergistic anti-viral effect. Pharmaceutical compositions comprising artemisone and at least one of said antiviral compounds are provided as well.


Find Patent Forward Citations

Loading…